0002088485-26-000001.txt : 20260417 0002088485-26-000001.hdr.sgml : 20260417 20260417121551 ACCESSION NUMBER: 0002088485-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260417 DATE AS OF CHANGE: 20260417 EFFECTIVENESS DATE: 20260417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tinos Therapeutics, Inc. CENTRAL INDEX KEY: 0002088485 ORGANIZATION NAME: EIN: 923339664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-558952 FILM NUMBER: 26870597 BUSINESS ADDRESS: STREET 1: 34 BOYCE AVENUE CITY: BARRINGTON STATE: RI ZIP: 02806 BUSINESS PHONE: 570-939-7415 MAIL ADDRESS: STREET 1: 34 BOYCE AVENUE CITY: BARRINGTON STATE: RI ZIP: 02806 D/A 1 primary_doc.xml X0708 D/A LIVE 0002088485 Tinos Therapeutics, Inc. 700 MAIN STREET CAMBRIDGE MA MASSACHUSETTS 02139 570-939-7415 DELAWARE None None Corporation true 2023 Nikolaos Tapinos 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director David Karambizi 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Anastasios Polimenakos 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b true 0002088485-25-000001 2025-09-04 true true false 0 4000000 2250000 1750000 false 3 0 0 0 false Tinos Therapeutics, Inc. /s/ Nikolaos Tapinos Nikolaos Tapinos President 2026-04-17